Brendan Teehan insider trades

Open-market stock purchases and sales by Brendan Teehan, Chief Commercial Officer at Pacira BioSciences, Inc, from SEC Form 4 filings since Nov 17, 2021.

Recent trades

DateStockTradeValue
Feb 11, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Jan 30, 2026PCRX Pacira BioSciences, IncSold (not open market)$106K
Dec 31, 2025PCRX Pacira BioSciences, IncBought (not open market)$4.3K

Companies traded

  • PCRX Pacira BioSciences, Inc: other filings, last Feb 11, 2026
  • ACAD Acadia Pharmaceuticals Inc: 16 sales, last Nov 19, 2024

Get free alerts when Brendan Teehan files a new trade →